UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of Third‐Generation Drugs on the Activity of First‐Line Chemotherapy in Advanced Non‐Small Cell Lung Cancer: A Meta‐Analytical Approach

The oncologist (Dayton, Ohio), 2009-05, Vol.14 (5), p.497-510

2009

Volltextzugriff (PDF)

Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience

BMC research notes, 2012-09, Vol.5 (1), p.482-482, Article 482

2012

Volltextzugriff (PDF)

Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.1086-1097

2022

Volltextzugriff (PDF)

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial

JNCI : Journal of the National Cancer Institute, 2003-03, Vol.95 (5), p.362-372

2003

Volltextzugriff (PDF)

From Diagnostic‐Therapeutic Pathways to Real‐World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR‐Positive Non‐Small Cell Lung Cancer (MOST Study)

The oncologist (Dayton, Ohio), 2019-06, Vol.24 (6), p.e318-e326

2019

Volltextzugriff (PDF)

The Impact of Progenitor Enrichment, Serum, and Cytokines on the Ex Vivo Expansion of Mobilized Peripheral Blood Stem Cells: A Controlled Trial

Stem cells (Dayton, Ohio), 2003-01, Vol.21 (1), p.33-40

2003

Volltextzugriff (PDF)

Randomized cross-over study of patient preference for oral or intravenous vinorelbine in the treatment of advanced NSCLC: A phase IV study

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20676-e20676

2017

Volltextzugriff (PDF)

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials

The lancet oncology, 2005-09, Vol.6 (9), p.669-677

2005

Volltextzugriff (PDF)

Efficacy of the addition of cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicenter, randomized phase III MILES-3 and MILES-4 studies

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.9002-9002

2017

Volltextzugriff (PDF)

Abstract P3-13-02: Phase II randomised clinical study of first line chemotherapy plus metformin versus first line chemotherapy alone in HER2 negative, non diabetic, metastatic breast cancer patients: Final results of the MYME study

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P3-P3-13-02

2015

Volltextzugriff (PDF)

Addition of bevacizumab to erlotinib as first-line treatment of patients with EGFR-mutated advanced nonsquamous non-small cell lung cancer. The BEVERLY multicenter randomized phase III trial

Journal of thoracic oncology, 2022-06

2022

Volltextzugriff (PDF)

Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non–Small-cell Lung Cancer: A Multicenter Italian Survey

Clinical lung cancer, 2017-07, Vol.18 (4), p.381-387

2017

Volltextzugriff (PDF)

The Iconography of Power: From Machiavelli’s Portraits to the Pop Art

Machiavelli in Contemporary Media, 2021, p.11-28

2021

Volltextzugriff (PDF)

Phase I-II Trial of Gemcitabine-Based First-Line Chemotherapies for Small Cell Lung Cancer in Elderly Patients with Performance Status 0-2: The G-Step Trial

Journal of thoracic oncology, 2012-01, Vol.7 (1), p.233-242

2012

Volltextzugriff (PDF)

Il paratesto nel cinema. Problematiche e prospettive

Paratesto, 2007 (4)

2007

Volltextzugriff (PDF)

B2-07: Impact of 3rd generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer (NSCLC): a meta-analytical approach

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S339-S339

2007

Volltextzugriff (PDF)

The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients

Lung cancer (Amsterdam, Netherlands), 2008-07, Vol.61 (1), p.67-72

2008

Volltextzugriff (PDF)

Hypnosis in the Treatment of Anticipatory Nausea and Vomiting in Patients Receiving Cancer Chemotherapy

Oncology, 2000-01, Vol.59 (2), p.100-104

2000

Volltextzugriff (PDF)

O-61 “Non progression” is a reliable endpoint of activity in advanced/metastatic NSCLC, when quality of life assessment is the primary endpoint of efficacy

Lung cancer (Amsterdam, Netherlands), 2003-08, Vol.41, p.S21-S21

2003

Volltextzugriff (PDF)

Salvage Therapy with Capecitabine Plus Weekly Paclitaxel in Heavily Pretreated Advanced Breast Cancer: A Multicenter Phase II Study

American journal of cancer (Auckland, N.Z.), 2005, Vol.4 (5), p.307-313

2005

Volltextzugriff (PDF)

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial

Breast cancer research and treatment, 2019-04, Vol.174 (2), p.433-442

2019

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(54)

Publikationsform

Artikel
(56)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(33)
Humans
(29)
Female
(22)
Oncology
(22)
Male
(18)
Aged
(14)
Lung Neoplasms - Drug Therapy
(11)
Aged, 80 And Over
(10)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(10)
Middle Aged
(10)
Adult
(9)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(8)
Cell Line, Tumor
(7)
Quality Of Life
(7)
Apoptosis - Drug Effects
(6)
Biological And Medical Sciences
(6)
Cell Biology
(6)
Deoxycytidine - Administration & Dosage
(6)
Deoxycytidine - Analogs & Derivatives
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Impact of Third‐Generation Drugs on the Activity of First‐Line Chemotherapy in Advanced Non‐Small Cell Lung Cancer: A Meta‐Analytical Approach

Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study

Re-challenge with pemetrexed in advanced mesothelioma: a multi-institutional experience

Cisplatin-Based First-Line Treatment of Elderly Patients With Advanced Non-Small-Cell Lung Cancer: Joint Analysis of MILES-3 and MILES-4 Phase III Trials

Addition of Bevacizumab to Erlotinib as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous NSCLC: The BEVERLY Multicenter Randomized Phase 3 Trial

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial

From Diagnostic‐Therapeutic Pathways to Real‐World Data: A Multicenter Prospective Study on Upfront Treatment for EGFR‐Positive Non‐Small Cell Lung Cancer (MOST Study)

The Impact of Progenitor Enrichment, Serum, and Cytokines on the Ex Vivo Expansion of Mobilized Peripheral Blood Stem Cells: A Controlled Trial

Effect on quality of life of cisplatin added to single-agent chemotherapy as first-line treatment for elderly patients with advanced non-small cell lung cancer: Joint analysis of MILES-3 and MILES-4 randomised phase 3 trials

Randomized cross-over study of patient preference for oral or intravenous vinorelbine in the treatment of advanced NSCLC: A phase IV study

Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials

Efficacy of the addition of cisplatin to single-agent first-line chemotherapy in elderly patients with advanced non-small cell lung cancer (NSCLC): A joint analysis of the multicenter, randomized phase III MILES-3 and MILES-4 studies

Abstract P3-13-02: Phase II randomised clinical study of first line chemotherapy plus metformin versus first line chemotherapy alone in HER2 negative, non diabetic, metastatic breast cancer patients: Final results of the MYME study

Addition of bevacizumab to erlotinib as first-line treatment of patients with EGFR-mutated advanced nonsquamous non-small cell lung cancer. The BEVERLY multicenter randomized phase III trial

Patients' Attitudes and Physicians' Perceptions Toward Maintenance Therapy for Advanced Non–Small-cell Lung Cancer: A Multicenter Italian Survey

The Iconography of Power: From Machiavelli’s Portraits to the Pop Art

Patients’ attitudes and physicians’ perceptions toward maintenance therapy for advanced Non Small Cell Lung Cancer: a multicentre Italian Survey

Phase I-II Trial of Gemcitabine-Based First-Line Chemotherapies for Small Cell Lung Cancer in Elderly Patients with Performance Status 0-2: The G-Step Trial

Il paratesto nel cinema. Problematiche e prospettive

B2-07: Impact of 3rd generation drugs on the activity of first-line chemotherapy in advanced non-small cell lung cancer (NSCLC): a meta-analytical approach

The MILES-2G phase 2 study of single-agent gemcitabine with prolonged constant infusion in advanced non-small cell lung cancer elderly patients

Hypnosis in the Treatment of Anticipatory Nausea and Vomiting in Patients Receiving Cancer Chemotherapy

O-61 “Non progression” is a reliable endpoint of activity in advanced/metastatic NSCLC, when quality of life assessment is the primary endpoint of efficacy

Salvage Therapy with Capecitabine Plus Weekly Paclitaxel in Heavily Pretreated Advanced Breast Cancer: A Multicenter Phase II Study

Metformin plus chemotherapy versus chemotherapy alone in the first-line treatment of HER2-negative metastatic breast cancer. The MYME randomized, phase 2 clinical trial

Suchergebnisse filtern